Skip to content

Therapeutic effect of lumbar intradiskal platelet-rich plasma injections versus radiofrequency thermocoagulation on discogenic low back pain: a prospective, randomized, controlled clinical study

Therapeutic effect of lumbar intradiskal platelet-rich plasma injections versus radiofrequency thermocoagulation on discogenic low back pain: a prospective, randomized, controlled clinical study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024268
Enrollment
Unknown
Registered
2019-07-04
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discogenic low back pain

Interventions

treatment group : lumbar intradiskal injection of Platelet-rich plasma
Control group:Intervertebral disc radiofrequency thermocoagulation

Sponsors

The Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The clinical diagnosis is discogenic low back pain, and Refractory low back pain persisting for >3 months. 2. Ineffective treatment of conservative treatment (oral medication, rehabilitation therapy, nerve block, etc.). 3. Maintained intervertebral disk height of at least 50%. 4. Disk protrusion less than 5 mm on magnetic resonance imaging or computed tomography scan. 5. Concordant pain on diskography. 6. Presence of a grade 3 or 4 annular fissure as determined by diskography. 7. Absent contraindications (eg, spinal stenosis).

Exclusion criteria

Exclusion criteria: 1. Coagulation disorders. 2. Currently used anticoagulation therapy. 3. Pregnant women. 4. Puncture site skin infection. 5. Contrast agent allergy. 6. There are mental illnesses (post-traumatic stress disorder, schizophrenia, etc.). 7. Intervertebral disc fusion, severe spinal stenosis, history of spinal surgery, vertebral spondylolisthesis, etc.

Design outcomes

Primary

MeasureTime frame
SF-36 questionnaire;Oswestry Disability Index;VAS visual analogue pain scale;

Countries

China

Contacts

Public ContactZhang Jianbo

The Second Affiliated Hospital of Guangzhou Medical University

granty18@163.com+86 13729857617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026